194 related articles for article (PubMed ID: 29137069)
1. Graves disease following radioiodine therapy for toxic adenoma: Clinical case report.
Shen G; Cui F; Huang R; Kuang A
Medicine (Baltimore); 2017 Nov; 96(45):e8550. PubMed ID: 29137069
[TBL] [Abstract][Full Text] [Related]
2. Radioiodine Therapy-Induced Conversion of Toxic Adenoma to Graves' Disease.
Rehman A; Obici S; Yaqub A
Cureus; 2020 Jun; 12(6):e8683. PubMed ID: 32699683
[TBL] [Abstract][Full Text] [Related]
3. Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease.
Schmidt M; Gorbauch E; Dietlein M; Faust M; Stützer H; Eschner W; Theissen P; Schicha H
Thyroid; 2006 Mar; 16(3):281-8. PubMed ID: 16571091
[TBL] [Abstract][Full Text] [Related]
4. Appearance of anti TSH-receptor antibodies and clinical Graves' disease after radioiodine therapy for hyperfunctioning thyroid adenoma.
Regalbuto C; Salamone S; Scollo C; Vigneri R; Pezzino V
J Endocrinol Invest; 1999 Feb; 22(2):147-50. PubMed ID: 10195384
[TBL] [Abstract][Full Text] [Related]
5. Development of Graves' disease following radioiodine treatment for autonomously functioning thyroid adenoma: case report.
Martinko J; Cigrovski-Berković M; Becejac B; Solter D; Solter M
Acta Clin Croat; 2011 Dec; 50(4):615-7. PubMed ID: 22649896
[TBL] [Abstract][Full Text] [Related]
6. Acute pre-tibial myxoedema following radioiodine therapy for thyrotoxic Graves' disease.
Harvey RD; Metcalfe RA; Morteo C; Furmaniak W; Weetman AP; Bevan JS
Clin Endocrinol (Oxf); 1995 Jun; 42(6):657-60; discussion 661. PubMed ID: 7634509
[TBL] [Abstract][Full Text] [Related]
7. Effects of radioiodine therapy in hyperthyroidism (thyroid function, thyroid volume, Graves' ophtalmopathy, thyrotoxic heart disease).
Ursu HI; Dumitriu L; Grigorie D; Simescu M; Vaida E; Belgun M; Popovici D
Rom J Endocrinol; 1993; 31(3-4):155-63. PubMed ID: 7697064
[TBL] [Abstract][Full Text] [Related]
8. Appearance of thyroid stimulating antibody and Graves' disease after radioiodine therapy for toxic nodular goitre.
Chiovato L; Santini F; Vitti P; Bendinelli G; Pinchera A
Clin Endocrinol (Oxf); 1994 Jun; 40(6):803-6. PubMed ID: 8033373
[TBL] [Abstract][Full Text] [Related]
9. 123I Scintigraphy Mirror Image of Graves Disease Induced by Radioiodine Treatment for Toxic Adenoma.
Lugat A; Drui D; Bach-Ngohou K; Guillot P; Mourrain-Langlois E; Kraeber-Bodéré F; Ansquer C
Clin Nucl Med; 2022 Feb; 47(2):e197-e198. PubMed ID: 35006119
[TBL] [Abstract][Full Text] [Related]
10. [Development of Basedow disease after radioiodine therapy for nodular goiter].
Cseke B; Balázs C
Orv Hetil; 2003 Nov; 144(47):2327-9. PubMed ID: 14725052
[TBL] [Abstract][Full Text] [Related]
11. Early complications of radioiodine treatment for hyperthyroidism.
Segers O; Musch W; Schoors DF
Acta Clin Belg; 1993; 48(4):253-8. PubMed ID: 8212977
[TBL] [Abstract][Full Text] [Related]
12. [Predicting the recurrence of thyrotoxicosis after iodine radioisotope therapy of diffuse toxic goiter].
Ametov AS; Livshits AKh; Oleĭnik EK
Probl Endokrinol (Mosk); 1988; 34(1):13-6. PubMed ID: 3362805
[TBL] [Abstract][Full Text] [Related]
13. Vitamin B12 levels are not affected by radioiodine ablation of the thyroid.
Potham SK; Vaikkakara S; Sachan A; Rao SP; Kalawat TC; Ravi P; Sunil E; Rajitha D; Arun M; Sailaja A
Endocr Regul; 2014 Apr; 48(2):77-85. PubMed ID: 24824803
[TBL] [Abstract][Full Text] [Related]
14. Predicting outcomes and complications following radioiodine therapy in Graves' thyrotoxicosis.
Aung ET; Zammitt NN; Dover AR; Strachan MWJ; Seckl JR; Gibb FW
Clin Endocrinol (Oxf); 2019 Jan; 90(1):192-199. PubMed ID: 30291728
[TBL] [Abstract][Full Text] [Related]
15. Follicular carcinoma of the thyroid following radioactive iodine treatment for Graves' disease.
Staffurth JS; Holl-Allen RT
Postgrad Med J; 1988 Nov; 64(757):878-80. PubMed ID: 3255938
[TBL] [Abstract][Full Text] [Related]
16. The effect of antithyroid drug pretreatment on acute changes in thyroid hormone levels after (131)I ablation for Graves' disease.
Burch HB; Solomon BL; Cooper DS; Ferguson P; Walpert N; Howard R
J Clin Endocrinol Metab; 2001 Jul; 86(7):3016-21. PubMed ID: 11443161
[TBL] [Abstract][Full Text] [Related]
17. [Thyrotoxicosis in a patient with Turner syndrome: radioactive iodine therapy].
Guseinova RM; Prosvirnina AA; Korchagina MO; Trukhin AA; Sheremeta MS
Probl Endokrinol (Mosk); 2022 Jul; 68(6):49-58. PubMed ID: 36689711
[TBL] [Abstract][Full Text] [Related]
18. Takotsubo cardiomyopathy following radioiodine therapy for toxic multinodular goitre.
van de Donk NW; America YG; Zelissen PM; Hamer BJ
Neth J Med; 2009 Nov; 67(10):350-2. PubMed ID: 19915229
[TBL] [Abstract][Full Text] [Related]
19. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
Franklyn JA; Daykin J; Holder R; Sheppard MC
QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
[TBL] [Abstract][Full Text] [Related]
20. [Radioiodine treatment of benign thyroid diseases].
Konrády A
Orv Hetil; 2006 Sep; 147(37):1783-9. PubMed ID: 17131798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
